Phosphomannomutase 2 hyperinsulinemia: Recent advances of genetic pathogenesis, diagnosis, and management. [PDF]
Chen C, Sang Y.
europepmc +1 more source
Architects of folding, editors of immunity: the strategic use of <i>N</i>-glycans in vaccine design. [PDF]
Orioli S +3 more
europepmc +1 more source
NGLY1 as an Emerging Critical Modulator for Neurodevelopment and Pathogenesis in the Brain. [PDF]
Zhang H, Xue H, Wang YC, Liu Y.
europepmc +1 more source
Predicting disease-overarching therapeutic approaches for congenital disorders of glycosylation using multi-OMICS. [PDF]
Muffels IJJ +5 more
europepmc +1 more source
Unmasking genetic etiologies in neurodevelopmental disorders characterized by Cerebral Palsy: insights from integrative genomic approaches. [PDF]
Yigit A +13 more
europepmc +1 more source
Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease. [PDF]
Reina-Llompart N +3 more
europepmc +1 more source
Dynamic glycosylation remodeling in neurological disorders. [PDF]
Xing D +6 more
europepmc +1 more source
TUSC3 serves as a rate-limiting gatekeeper of a glycan-mediated ER triage checkpoint for BMP4/Dpp. [PDF]
Galeone A +9 more
europepmc +1 more source
Expanding carrier screening: beyond the genes, to include underrepresented ancestries. [PDF]
Bylstra Y +12 more
europepmc +1 more source
Adrenal insufficiency in inborn errors of metabolism and vice versa: Case reports and review of the literature. [PDF]
De Preter A +3 more
europepmc +1 more source

